Quantinno Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$44.9M Buy
200,036
+80,061
+67% +$20M 0.07% 307
2025
Q4
$28.9M Sell
119,975
-197
-0.2% -$50.4K 0.06% 392
2025
Q3
$32.9M Buy
120,172
+34,968
+41% +$9.55M 0.09% 250
2025
Q2
$22M Buy
85,204
+15,016
+21% +$3.58M 0.09% 234
2025
Q1
$15.7M Buy
70,188
+31,608
+82% +$7.38M 0.1% 215
2024
Q4
$8.82M Buy
38,580
+13,942
+57% +$3.36M 0.09% 240
2024
Q3
$6.01M Buy
24,638
+9,166
+59% +$2.05M 0.08% 285
2024
Q2
$2.96M Buy
15,472
+2,325
+18% +$472K 0.05% 435
2024
Q1
$2.6M Buy
13,147
+4,444
+51% +$814K 0.06% 409
2023
Q4
$1.5M Buy
8,703
+4,459
+105% +$685K 0.05% 483
2023
Q3
$628K Buy
4,244
+1,826
+76% +$330K 0.03% 655
2023
Q2
$528K Buy
+2,418
New +$539K 0.03% 617
2021
Q4
Sell
-2,269
Closed -$598K 542
2021
Q3
$598K Buy
2,269
+20
+0.9% +$5.47K 0.67% 28
2021
Q2
$554K Hold
2,249
0.63% 34
2021
Q1
$436K Hold
2,249
0.48% 75
2020
Q4
$478K Sell
2,249
-1,117
-33% -$223K 0.37% 91
2020
Q3
$577K Buy
3,366
+309
+10% +$57.1K 0.39% 50
2020
Q2
$587K Sell
3,057
-876
-22% -$143K 0.58% 3
2020
Q1
$579K Sell
3,933
-555
-12% -$88.4K 0.36% 95
2019
Q4
$696K Buy
4,488
+1,751
+64% +$252K 0.44% 30
2019
Q3
$370K Buy
+2,737
New +$359K 0.25% 193
2019
Q1
Sell
-2,798
Closed -$319K 450
2018
Q4
$319K Buy
+2,798
New +$300K 0.26% 170

Other funds holding RMD

Quantinno Capital Management's RMD Position: Q1 2026 in Review

Quantinno Capital Management increased its ResMed (RMD) stake by 67% in Q1 2026, buying an estimated $20M and bringing the position to 200,036 shares worth $44.9M. The position accounts for 0.07% of the portfolio, ranked #307.

Quantinno Capital Management first reported a position in RMD in Q4 2018 and has held it in 22 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Quantinno Capital Management held 200,036 shares of ResMed worth $44.9M as of Q1 2026.
  • Quantinno Capital Management bought 80,061 ResMed shares in Q1 2026, an estimated $20M.
  • ResMed made up 0.07% of Quantinno Capital Management's portfolio in Q1 2026, its #307 holding.
  • Quantinno Capital Management first reported a position in ResMed in Q4 2018 and has held it in 22 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.